Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07454603Not Yet Recruiting

A Prospective Clinical Trial Evaluating PROSTest, a Blood-Based Molecular Assay, for Risk Stratification and Biopsy Decision Support in Men With Suspected Prostate Cancer

Role: lead

NCT02270567Enrolling By Invitation

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

Role: lead

NCT06907303Enrolling By Invitation

RNA Assays for Endometriosis Detection and Diagnosis

Role: lead

NCT06872619Enrolling By Invitation

RegisterPROS - a Registry for Prostate Cancers

Role: lead

NCT03012789Not ApplicableActive Not Recruiting

Surgical Intervention and the NETest

Role: lead

NCT03267381Completed

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

Role: collaborator

All 6 trials loaded